To examine the effects of dasatinib on glioma cell viability, U87 and U373 cells were treated with a range of concentrations of dasatinib in complete medium for 48 h, stained with both propidium iodide and Annexin V, and analyzed by fluorescence-activated cell sorting analysis. Here, ANXA5 is linked to central nervous system cancer.